Jamie Rich

Director, Technology, ADC Therapeutic Development at Zymeworks

Speaker

Jamie Rich is Senior Director of Technology in the ADC Therapeutic Development Department at Zymeworks, where his team focuses on discovery and pipeline application of new ADC technologies. Dr. Rich is a co-inventor of multiple technologies and assets associated with Zymeworks’ ZymeLink™, preCYSion, and Topoisomerase 1 inhibitor ADC platforms. His group is currently interested in the design principles which enable antibody drug conjugates to improve upon the efficacy of small molecule chemotherapies in some instances.